港股收評:三大指數齊跌,金融股低迷,黃金、生物醫藥股走強
港股三大指數呈現高開低走行情,市場情緒全天表現疲弱。截止收盤,恒生指數跌0.6%,國企指數跌0.64%,恒生科技指數跌0.78%。

盤面上,大型科技股多數出現下跌行情,大金融股(銀行、保險、券商)、基建類中字頭等權重多數表現低迷拖累大市下行;軍工股、家電股、鋰電池股、汽車股、內房股、半導體芯片股紛紛下跌。另一方面,創新藥成果即將亮相國際會議,生物醫藥股全線走強,藥明合聯升超9%,互聯網醫療龍頭平安好醫生更是升超10%;金價迭創新高,大摩上調金價年底目標至3800美元/盎司,黃金股持續上升,靈寶黃金、招金礦業、山東黃金盤中均創歷史高位,帶領銅等有色金屬股齊升。

具體來看:
大型科技股多數下跌,比亞迪電子跌超4%,美的集團、比亞迪股份、小鵬汽車、小米集團跌超2%,網易、華虹半導體等跟跌。

軍工股跌幅居前,中船防務跌超8%,大陸航空科技跌超5%,中航科工跌超4%。

中資券商股大跌,國聯民生跌超5%,中州證券、國泰海通、中金公司跌超3%,中信建投證券、光大證券等跟跌。

內房股普遍走低,世茂集團跌超6%,中國金茂、雅居樂集團、萬科企業跌超3%,新城發展、遠洋集團等跟跌。

消息上,國盛證券研報指出,8月房地產市場整體延續調整態勢,百強房企銷售金額環比繼續下降,單月銷售降幅因上年基數較低而收窄,累計同比降幅進一步擴大。
互聯網醫療股拉昇,平安好醫生一度升超16%表現十分搶眼,刷新階段新高,最終收升10.49%,方舟健客升超7%,阿里健康升超4%,京東健康、叮噹健康跟升。

消息面上,2025年世界肺癌大會(WCLC)將於9月6日~9月9日在西班牙巴塞羅那舉行,中國藥企將在會議上展示一系列創新藥成果。根據公開信息,康方生物、百濟神州、百利天恒等中國藥企將在會議期間發佈最新研究進展。
黃金及貴金屬股走高,招金礦業、靈寶黃金升超6%,紫金礦業、集海資源、山東黃金等跟升。

消息面上,摩根士丹利將金價年底目標上調至3800美元/盎司。大摩強調,黃金與美元的負相關性仍是核心定價邏輯,若美元繼續走弱,將有利於貴金屬價格走勢。
光伏股股集體上升,協鑫新能源升超9%,福耀玻璃升超4%,信義能源、福萊特玻璃跟升。

消息上,9月1日,市場有消息稱,多晶硅產業重組將按照預期推進,有企業高管透露,更多信息將很快公佈。截至8月20日,國內光伏領域今年新增擬擴產項目32個,這些項目當前分別處於簽約、環評、備案、募資等狀態。同期,還有14個光伏製造項目開工。
今日,南向資金淨買入55.08億港元,其中港股通(滬)淨買入32.02億港元,港股通(深)淨買入23.07億港元。

展望後市,國泰海通證券認為,存量視角看,港股外資持股市值佔比高,偏好代表中國新經濟動力的科技互聯網板塊,以及依託於國家信用體系的大金融板塊。流量視角看,24/01-25/04期間外資大量流出港股,但逆勢流入部分科技+消費,25/05以來一致流入科技。隨着壓制港股科技的負面因素出現積極變化,估值低位、基本面更優的港股科技板塊有望繼續獲得外資青睞。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.